-
41
-
42
-
43
-
44
-
45
Computational frameworks transform antagonism to synergy in optimizing combination therapies
Published 2025-01-01Get full text
Article -
46
-
47
-
48
-
49
-
50
-
51
-
52
Impact of Timing the Combination of Radiotherapy and PD-1 Inhibitors on Outcomes in Patients with Hepatocellular Carcinoma
Published 2025-01-01“…Liting Zhong,1,2,* Weiwei Peng,1,2,* Jingyuan Sun,3 Yongyi Luo,3 Hailong Sheng,4 Yi Wu,5 Tonggang Zhou,5 Chaoming Zhou,1,2 Chuanhui Cao1,3 1Department of Oncology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, Jiangxi, People’s Republic of China; 2Department of Oncology, Ganzhou People’s Hospital, Ganzhou, Jiangxi, People’s Republic of China; 3Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 4Department of Radiation Oncology, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China; 5Department of Interventional Radiology, Ganzhou People’s Hospital, Ganzhou, Jiangxi, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chuanhui Cao, Department of Oncology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, No. 16 Meiguan Avenue, Ganzhou, Jiangxi, People’s Republic of China, Email huichuancao@163.comPurpose: The optimal timing for combining radiotherapy with immunotherapy in patients with hepatocellular carcinoma (HCC) remains uncertain and affects treatment efficacy and patient outcomes. …”
Get full text
Article -
53
LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
Published 2021-01-01Get full text
Article -
54
-
55
Exosomes from LPS-Stimulated hDPSCs Activated the Angiogenic Potential of HUVECs In Vitro
Published 2021-01-01Get full text
Article -
56
Artificial intelligence‐driven change redefining radiology through interdisciplinary innovation
Published 2025-01-01Get full text
Article -
57
Peptide Aptamer–Paclitaxel Conjugates for Tumor Targeted Therapy
Published 2024-12-01Get full text
Article -
58
Advancements in 3D printing technologies for personalized treatment of osteonecrosis of the femoral head
Published 2025-04-01Get full text
Article -
59
-
60